157 related articles for article (PubMed ID: 1338078)
1. Angiotensin II increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells via the angiotensin II AT1 receptor.
Lyall F; Dornan ES; McQueen J; Boswell F; Kelly M
J Hypertens; 1992 Dec; 10(12):1463-9. PubMed ID: 1338078
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
[TBL] [Abstract][Full Text] [Related]
3. Mechanical stretch increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells.
Lyall F; Deehan MR; Greer IA; Boswell F; Brown WC; McInnes GT
J Hypertens; 1994 Oct; 12(10):1139-45. PubMed ID: 7836729
[TBL] [Abstract][Full Text] [Related]
4. EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells.
Sachinidis A; Ko Y; Weisser P; Meyer zu Brickwedde MK; Düsing R; Christian R; Wieczorek AJ; Vetter H
J Hypertens; 1993 Feb; 11(2):155-62. PubMed ID: 8385175
[TBL] [Abstract][Full Text] [Related]
5. Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.
Freeman EJ; Tallant EA
Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):543-8. PubMed ID: 7998990
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.
Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM
J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814
[TBL] [Abstract][Full Text] [Related]
7. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
[TBL] [Abstract][Full Text] [Related]
8. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
Cox SL; Story DF; Ziogas J
Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
[TBL] [Abstract][Full Text] [Related]
10. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
11. HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro.
Dunn FW; Roux MH; Farhadian F; Sabri K; Ossart C; Samuel JL; Rappaport L; Hamon G
J Pharmacol Exp Ther; 1997 Jan; 280(1):447-53. PubMed ID: 8996227
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes.
Kramár EA; Harding JW; Wright JW
Regul Pept; 1997 Jan; 68(2):131-8. PubMed ID: 9110385
[TBL] [Abstract][Full Text] [Related]
13. Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-beta 1.
Liu G; Espinosa E; Oemar BS; Lüscher TF
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1251-7. PubMed ID: 9261254
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells.
Saward L; Zahradka P
J Mol Cell Cardiol; 1996 Mar; 28(3):499-506. PubMed ID: 9011633
[TBL] [Abstract][Full Text] [Related]
15. Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Hirata Y; Kanno K; Eguchi S; Kano H
Blood Press Suppl; 1994; 5():84-8. PubMed ID: 7889209
[TBL] [Abstract][Full Text] [Related]
16. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
17. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro.
Herbert JM; Delisée C; Dol F; Schaeffer P; Cazaubon C; Nisato D; Chatelain P
Eur J Pharmacol; 1994 Jan; 251(2-3):143-50. PubMed ID: 8149971
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
[TBL] [Abstract][Full Text] [Related]
19. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope LM; Lahera V; Cachofeiro V
Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
[TBL] [Abstract][Full Text] [Related]
20. Binding of valsartan to mammalian angiotensin AT1 receptors.
de Gasparo M; Whitebread S
Regul Pept; 1995 Nov; 59(3):303-11. PubMed ID: 8577935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
